Get started
Author

Meng Jiang

The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial
2024 · Iokfai Cheang, Wenming Yao, et al. · Nature Medicine · 106
PDF
Amifostine-Loaded Nanocarrier Traverses the Blood–Brain Barrier and Prevents Radiation-Induced Brain Injury
2023 · XiaoHui Zhao, JinPing Cheng, et al. · ACS Applied Materials & Interfaces · 32
Roles of oral and gut microbiota in acute myocardial infarction
2024 · Yu-Lin Li, Bo-Yan Chen, et al. · Journal of Advanced Research · 21
Heparin Therapy and Mortality in Patients with Sepsis: An Observational Study Using a Marginal Structural Cox Model Based on MIMIC-IV Database
2024 · Meng Jiang, Xiao-peng Wu, et al. · Intensive Care Research · 2
T1 finite element model of Kümmell's disease shows changes in the vertebral stress distribution.
2015 · Yunshan Su, Dong Ren, et al. · PubMed · 1
HJURP upregulation, driven by transcription factor NFYA, promotes endometrial carcinoma progression via regulating RASSF8 ubiquitination
2026 · Meng Jiang, Xinyu Xu, et al. · Functional & Integrative Genomics
A commentary on “Evaluation of the comparative efficacy and safety of surgical strategies for long bone defects: a network meta-analysis”
2025 · Mm Fei Jiang, Mm He Hu · International Journal of Surgery
Plasma Nucleosomes as Biomarker for Sepsis and Organ Failure
2025 · D. Filippini, M. Jiang, et al. · American Journal of Respiratory and Critical Care Medicine
Supplementary Table S1 from Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
2023 · Jian-Jun Zhao, Zhang-Bo Chu, et al.
Supplementary Figure Legends from Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
2023 · Jian-Jun Zhao, Zhang-Bo Chu, et al.
Supplementary Figure S2 from Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
2023 · Jian-Jun Zhao, Zhang-Bo Chu, et al.
Supplementary Figure S1 from Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
2023 · Jian-Jun Zhao, Zhang-Bo Chu, et al.
Supplementary Figure S3 from Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
2023 · Jian-Jun Zhao, Zhang-Bo Chu, et al.
Data from Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
2023 · Jian-Jun Zhao, Zhang-Bo Chu, et al.
Advanced Breeding for Abiotic Stress Tolerance in Crops
2023 · Meng Jiang, Xinyang Wu, et al. · Frontiers research topics
Ameliorative efficacy of oxypaeoniflorin, a traditional chinese medicine monomer against adjuvant-induced arthritic inflammation and pain
2022 · Meng Jiang, Ke Lv · Pharmacognosy Magazine
Abstract 621: Basic Fibroblast Growth Factor Helps to Maintain the Stemness of Rat Multipotent Adult Progenitor Cells Partially via Erk1/2 Signaling
2017 · Qingyi Zhu, Meng Jiang, et al. · Arteriosclerosis Thrombosis and Vascular Biology
Effects of total flavone of Abelmoschus manihot on apoptosis and fas expression in human umbilical endothelial cells
2012 · Meng Jiang · Modern Medical Journal
Works count: 18
Citation count: 162
H-index: 3
I10-index: 3
Year
Topic
Type